Literature DB >> 18469100

VirB3 to VirB6 and VirB8 to VirB11, but not VirB7, are essential for mediating persistence of Brucella in the reticuloendothelial system.

Andreas B den Hartigh1, Hortensia G Rolán, Maarten F de Jong, Renée M Tsolis.   

Abstract

The Brucella abortus virB locus contains 12 open reading frames, termed virB1 through virB12, which encode a type IV secretion system. Polar mutations in the virB locus markedly reduce the ability of B. abortus to survive in cultured macrophages or to persist in organs of mice. While a nonpolar deletion of the virB2 gene reduces survival in cultured macrophages and in organs of mice, a nonpolar deletion of virB1 only reduces survival in macrophages, whereas virB12 is dispensable for either virulence trait. Here we investigated the role of the remaining genes in the virB locus during survival in macrophages and virulence in mice. Mutants carrying nonpolar deletions of the virB3, virB4, virB5, virB6, virB7, virB8, virB9, virB10, or virB11 gene were constructed and characterized. All mutations reduced the ability of B. abortus to survive in J774A.1 mouse macrophage-like cells to a degree similar to that caused by a deletion of the entire virB locus. Deletion of virB3, virB4, virB5, virB6, virB8, virB9, virB10, or virB11 markedly reduced the ability of B. abortus to persist in the spleens of mice at 8 weeks after infection. Interestingly, deletion of virB7 did not reduce the ability of B. abortus to persist in spleens of mice. We conclude that virB2, virB3, virB4, virB5, virB6, virB8, virB9, virB10, and virB11 are essential for virulence of B. abortus in mice, while functions encoded by the virB1, virB7, and virB12 genes are not required for persistence in organs with this animal model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18469100      PMCID: PMC2446811          DOI: 10.1128/JB.00406-08

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  66 in total

1.  Functional divergence and horizontal transfer of type IV secretion systems.

Authors:  A Carolin Frank; Cecilia M Alsmark; Mikael Thollesson; Siv G E Andersson
Journal:  Mol Biol Evol       Date:  2005-03-02       Impact factor: 16.240

2.  Dimerization and interactions of Brucella suis VirB8 with VirB4 and VirB10 are required for its biological activity.

Authors:  Athanasios Paschos; Gilles Patey; Durga Sivanesan; Chan Gao; Richard Bayliss; Gabriel Waksman; David O'callaghan; Christian Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

Review 3.  From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.

Authors:  Jacques Godfroid; Axel Cloeckaert; Jean-Pierre Liautard; Stephan Kohler; David Fretin; Karl Walravens; Bruno Garin-Bastuji; Jean-Jacques Letesson
Journal:  Vet Res       Date:  2005 May-Jun       Impact factor: 3.683

4.  Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking.

Authors:  Nadim Shohdy; Jem A Efe; Scott D Emr; Howard A Shuman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

5.  The Legionella pneumophila effector protein DrrA is a Rab1 guanine nucleotide-exchange factor.

Authors:  Takahiro Murata; Anna Delprato; Alyssa Ingmundson; Derek K Toomre; David G Lambright; Craig R Roy
Journal:  Nat Cell Biol       Date:  2006-08-13       Impact factor: 28.824

6.  A Legionella pneumophila-translocated substrate that is required for growth within macrophages and protection from host cell death.

Authors:  Rita K Laguna; Elizabeth A Creasey; Zhiru Li; Nicole Valtz; Ralph R Isberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-21       Impact factor: 11.205

7.  Swapping of periplasmic domains between Brucella suis VirB8 and a pSB102 VirB8 homologue allows heterologous complementation.

Authors:  Gilles Patey; Zhong Qi; Gisele Bourg; Christian Baron; David O'Callaghan
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

8.  Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host.

Authors:  Michel S Zygmunt; Sue D Hagius; Joel V Walker; Philip H Elzer
Journal:  Microbes Infect       Date:  2006-10-16       Impact factor: 2.700

9.  A bipartite signal mediates the transfer of type IV secretion substrates of Bartonella henselae into human cells.

Authors:  Ralf Schulein; Patrick Guye; Thomas A Rhomberg; Michael C Schmid; Gunnar Schröder; Annette C Vergunst; Ilaria Carena; Christoph Dehio
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-10       Impact factor: 11.205

10.  Mice lacking components of adaptive immunity show increased Brucella abortus virB mutant colonization.

Authors:  Hortensia García Rolán; Renée M Tsolis
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

View more
  34 in total

1.  An orphaned Mce-associated membrane protein of Mycobacterium tuberculosis is a virulence factor that stabilizes Mce transporters.

Authors:  Ellen Foot Perkowski; Brittany K Miller; Jessica R McCann; Jonathan Tabb Sullivan; Seidu Malik; Irving Coy Allen; Virginia Godfrey; Jennifer D Hayden; Miriam Braunstein
Journal:  Mol Microbiol       Date:  2016-02-05       Impact factor: 3.501

2.  Intracellular adaptation of Brucella abortus.

Authors:  Julie Lamontagne; Anik Forest; Elena Marazzo; François Denis; Heather Butler; Jean-François Michaud; Lyne Boucher; Ida Pedro; Annie Villeneuve; Dmitri Sitnikov; Karine Trudel; Najib Nassif; Djamila Boudjelti; Fadi Tomaki; Esteban Chaves-Olarte; Caterina Guzmán-Verri; Sylvain Brunet; Alexandra Côté-Martin; Joanna Hunter; Edgardo Moreno; Eustache Paramithiotis
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

Review 3.  Biological diversity of prokaryotic type IV secretion systems.

Authors:  Cristina E Alvarez-Martinez; Peter J Christie
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

Review 4.  Phylogenomics reveals a diverse Rickettsiales type IV secretion system.

Authors:  Joseph J Gillespie; Kelly A Brayton; Kelly P Williams; Marco A Quevedo Diaz; Wendy C Brown; Abdu F Azad; Bruno W Sobral
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

5.  A Brucella Type IV Effector Targets the COG Tethering Complex to Remodel Host Secretory Traffic and Promote Intracellular Replication.

Authors:  Cheryl N Miller; Erin P Smith; Jennifer A Cundiff; Leigh A Knodler; Jessica Bailey Blackburn; Vladimir Lupashin; Jean Celli
Journal:  Cell Host Microbe       Date:  2017-08-24       Impact factor: 21.023

Review 6.  The Intracellular Life Cycle of Brucella spp.

Authors:  Jean Celli
Journal:  Microbiol Spectr       Date:  2019-03

7.  Quorum-sensing and BvrR/BvrS regulation, the type IV secretion system, cyclic glucans, and BacA in the virulence of Brucella ovis: similarities to and differences from smooth brucellae.

Authors:  Ana I Martín-Martín; Pilar Sancho; María Jesús de Miguel; Luis Fernández-Lago; Nieves Vizcaíno
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

8.  Erythritol triggers expression of virulence traits in Brucella melitensis.

Authors:  Erik Petersen; Gireesh Rajashekara; Neelima Sanakkayala; Linda Eskra; Jerome Harms; Gary Splitter
Journal:  Microbes Infect       Date:  2013-02-16       Impact factor: 2.700

9.  Phospholipase A1 modulates the cell envelope phospholipid content of Brucella melitensis, contributing to polymyxin resistance and pathogenicity.

Authors:  Tobias Kerrinnes; Briana M Young; Carlos Leon; Christelle M Roux; Lisa Tran; Vidya L Atluri; Maria G Winter; Renée M Tsolis
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

10.  Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice.

Authors:  D M Magnani; J S Harms; M A Durward; G A Splitter
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.